Vivid Biosciences

Vivid Biosciences is a biotechnology company focused on advancing precision medicine through the use of patient-derived 3D micro-tumor models. Based at the HudsonAlpha Institute for Biotechnology, the company utilizes its proprietary platform to screen drug candidates and identify optimal therapeutic strategies for individual cancer patients. By bridging the gap between traditional cell cultures and clinical outcomes, Vivid Biosciences aims to accelerate drug discovery and improve patient responses in oncology. Their technology supports both pharmaceutical partners in drug development and clinicians in personalized treatment planning. The company's approach involves high-throughput screening of small molecules and biologics against functional tumor models that retain the genomic and phenotypic characteristics of the original patient.